38 research outputs found

    Readmission Following Surgical Stabilization of Rib Fractures

    No full text
    BACKGROUND: Surgical stabilization of rib fractures (SSRF) has become increasingly common for the treatment of traumatic rib fractures; however, little is known about related postoperative readmissions. The aims of this study were to determine the rate, and cost of readmissions as well as to identify patient, hospital, and injury characteristics that are associated with risk of readmission in patients who underwent SSRF. The null hypotheses were that readmissions following rib fixation were rare and unrelated to the SSRF complications. METHODS: This is a retrospective analysis of the 2015–2017 Nationwide Readmission Database. Adult patients with rib fractures treated by SSRF were included. Univariate and multivariate analyses were used to compare patients readmitted within 30 days to those who were not, based on demographics, comorbidities, and hospital characteristics. Financial information examined included average visit costs and national extrapolations. RESULTS: 2,522 patients who underwent SSRF were included, of whom 276 (10.9%) were readmitted within 30 days. In 36.2% of patients the reasons for readmissions were related to complications of rib fractures or SSRF. The rest of the patients (63.8%) were readmitted due to mostly non-trauma reasons (32.2%) and new traumatic injuries (21.1%) among other reasons. Multivariate analysis demonstrated that ventilator use, discharge other than home, smaller hospital size, and medical comorbidities were significantly associated with risk of readmission. Nationally, an estimated 2,498 patients undergo SSRF each year, with costs of 176millionforinitialadmissionsand176 million for initial admissions and 5.9 million for readmissions. CONCLUSIONS: Readmissions after SSRF are rare and mostly attributed to the reasons not directly related to sequelae of rib fractures or SSRF complications. Interventions aimed at optimizing patients’ pre-existing medical conditions prior to discharge should be further investigated as a potential way to decrease rates of readmission after SSRF. LEVEL OF EVIDENCE: Epidemiological study, level II

    Experimental and theoretical study of hydrogen desorption process from Mn(BH4)2

    No full text
    The thermal decomposition of manganese borohydride Mn(BH4)2 was studied by means of synchrotron-based X-ray absorption spectroscopy (XAS), X-ray powder diffraction (XRPD) and theoretical density functional (DFT) modeling aiming to elucidate changes of the local atomic structure upon hydrogen desorption and to determine possible decomposition reaction products. XRPD patterns indicate profound structural changes in the material above 120 °C with subsequent amorphization. DFT simulations predict the collapse of the highly porous framework structure upon hydrogen desorption and significant reduction of Mn-B and Mn-Mn interatomic distances by 19% and 41% respectively. These estimations are in a good agreement with the quantitative analysis of the X-ray absorption spectra above Mn K-edge. Based on XAS we derive possible decomposition products and reaction path. In particular, the amount of Mn metallic phase was estimated to be less than 5% after the heating up to 200 °C. Several structural models for the final state of manganese borohydride in a heating process are constructed by means of energy minimization in conjunction with evolutionary algorithms
    corecore